Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C. [electronic resource]
Producer: 20080328Description: 507-15 p. digitalISSN:- 1468-3288
- Adult
- Aged
- Antiviral Agents -- therapeutic use
- Biomarkers -- blood
- Cell Line, Transformed
- Drug Therapy, Combination
- Female
- Gene Expression Profiling -- methods
- Genetic Markers
- Haplotypes
- Hepatitis C, Chronic -- drug therapy
- Humans
- Interferon-alpha -- therapeutic use
- Male
- Middle Aged
- Polymorphism, Single Nucleotide
- Prognosis
- RNA, Messenger -- genetics
- Ribavirin -- therapeutic use
- Suppressor of Cytokine Signaling 3 Protein
- Suppressor of Cytokine Signaling Proteins -- blood
- Treatment Failure
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.